CD3 + CD4 − CD8 − T cells are a rare T lymphocyte subset that exerts anti-tumor effects through mechanisms such as the Fas/FasL pathway, cytokine secretion, and expression of tumor necrosis factor-associated apoptosis-inducing ligand (TRAIL)22,23. This evidence concerns the gene CD8A and neoplasm.